FDA OKs Pfizer’s Lipitor for use in diabetics

	Tweet

Pfizer Inc. said on Tuesday U.S. regulators have approved its blockbuster cholesterol drug Lipitor to reduce the risk of Stroke and Heart Attack in diabetic patients.

Pfizer said the approval is for patients with type 2, or adult onset, diabetes who have no signs of Heart disease but have multiple risk factors for the condition.

Common risk factors include High cholesterol, High Blood Pressure, a family history of Heart disease, Smoking and Obesity.

RELATED STORIES:
Chinese drugs driving down generic prices   Activists attack ethics of Pfizer AIDS drug trial   Viagra safe with blood pressure drugs, study shows   Drug makers create U.S. database for trial results   Parkinson’s Drugs Tradeoff: Better Muscle Control, Worse Side Effects   Back to Basics: Aspirin After Knee Surgery   New reference material can improve testing of multivitamin tablets   More research needed on painkiller safety   FDA approves Pfizer drug to help smokers   Doctors Reconsider Treatments with Painkillers   Progress made toward gonorrhea vaccine   Asthma, Emphysema Drug May Weaken Bones

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]